Financials Alpha Tau Medical Ltd.

Equities

DRTS

IL0011839383

Investment Holding Companies

Market Closed - Nasdaq 04:30:00 2024-07-05 pm EDT 5-day change 1st Jan Change
2.21 USD -0.90% Intraday chart for Alpha Tau Medical Ltd. -12.65% -26.58%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 337.6 219.5 209.1 155.6 - -
Enterprise Value (EV) 1 337.6 219.5 209.1 155.6 155.6 155.6
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue - - - - 151 x 22 x
EV / Revenue - - - - 151 x 22 x
EV / EBITDA - -7.04 x -6.04 x -4.24 x -3.42 x -10.4 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 34,375 69,012 69,474 69,797 - -
Reference price 2 9.820 3.180 3.010 2.230 2.230 2.230
Announcement Date 3/28/22 3/9/23 3/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - 1.03 7.081
EBITDA 1 - -31.16 -34.61 -36.71 -45.45 -14.91
EBIT 1 -13.79 -32.14 -35.68 -36.89 -45.23 -42.47
Operating Margin - - - - -4,391.71% -599.81%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/28/22 3/9/23 3/7/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 - - - - - - - - - - 0.025 0.05 0.15
EBITDA 1 - - - - - - - - -10.14 -8.634 -9.086 -9.604 -10.43
EBIT 1 -8.781 -8.012 -7.358 -7.985 -8.644 -8.168 -7.339 -9.943 -8.424 -8.917 -9.476 -10.08 -11.06
Operating Margin - - - - - - - - - - -37,903.08% -20,152.24% -7,372.46%
Earnings before Tax (EBT) - - - - - - - - - - - - -
Net income - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - -
EPS - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 5/26/22 8/25/22 11/22/22 3/9/23 5/23/23 8/28/23 11/16/23 3/7/24 5/20/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - -95.3% -30.7% -40.4% -41.5% -7.57%
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 2.93 0.9 6.4 4 6 -
Capex / Sales - - - - 582.52% -
Announcement Date 3/28/22 3/9/23 3/7/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.23 USD
Average target price
9.25 USD
Spread / Average Target
+314.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRTS Stock
  4. Financials Alpha Tau Medical Ltd.